Chi-Shuen Chu

462 total citations
10 papers, 316 citations indexed

About

Chi-Shuen Chu is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Chi-Shuen Chu has authored 10 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Immunology and 2 papers in Oncology. Recurrent topics in Chi-Shuen Chu's work include Genomics and Chromatin Dynamics (4 papers), Epigenetics and DNA Methylation (3 papers) and RNA Interference and Gene Delivery (3 papers). Chi-Shuen Chu is often cited by papers focused on Genomics and Chromatin Dynamics (4 papers), Epigenetics and DNA Methylation (3 papers) and RNA Interference and Gene Delivery (3 papers). Chi-Shuen Chu collaborates with scholars based in United States, Taiwan and Israel. Chi-Shuen Chu's co-authors include Pang‐Hung Hsu, Li‐Jung Juan, Yu‐Ching Teng, Chi‐Huey Wong, Ming-Lun Kang, Robert G. Roeder, Ari Melnick, Sohail Malik, Elisabeth Scheer and Ming‐Daw Tsai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Genes & Development.

In The Last Decade

Chi-Shuen Chu

9 papers receiving 315 citations

Peers

Chi-Shuen Chu

MB

IMMUN

OC

CR

ONCOL

Ming-Lun Kang Taiwan

Daisy Rymen Belgium

Thippeswamy Gulappa United States

Veronica M. Pravatà United Kingdom

Prabakaran Nagarajan United States

Akiyo Ogawa United States

Giulia Venturi Italy

Dawn Sijin Nin Singapore

Natalie Rezai‐Zadeh United States

Antonio Herrera-Merchan Spain

Ming-Lun Kang Taiwan

Chi-Shuen Chu

213 ×0.8

MB

66 ×0.8

IMMUN

52 ×1.0

OC

32 ×0.8

CR

18 ×0.9

ONCOL

Citations per year, relative to Chi-Shuen Chu Chi-Shuen Chu (= 1×) peers Ming-Lun Kang

Countries citing papers authored by Chi-Shuen Chu

Since Specialization

Citations

This map shows the geographic impact of Chi-Shuen Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi-Shuen Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi-Shuen Chu more than expected).

Fields of papers citing papers by Chi-Shuen Chu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi-Shuen Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi-Shuen Chu. The network helps show where Chi-Shuen Chu may publish in the future.

Co-authorship network of co-authors of Chi-Shuen Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Chi-Shuen Chu. A scholar is included among the top collaborators of Chi-Shuen Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi-Shuen Chu. Chi-Shuen Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Green, Jesse, Chi-Shuen Chu, Adam T. Hilterbrand, et al.. (2024). Enabling Potent T Cell Delivery and Mitigating Key Off-Target Concerns of In Vivo CAR T Lentiviral Vectors with the Targeted Paramyxovirus Fusogen System. Blood. 144(Supplement 1). 2047–2047. 2 indexed citations

2.

Nakadai, Tomoyoshi, Miho Shimada, Keiichi Ito, et al.. (2023). Two target gene activation pathways for orphan ERR nuclear receptors. Cell Research. 33(2). 165–183. 14 indexed citations

3.

Lee, Yu-Ling, Keiichi Ito, Wen‐Chieh Pi, et al.. (2021). Mediator subunit MED1 is required for E2A-PBX1–mediated oncogenic transcription and leukemic cell growth. Proceedings of the National Academy of Sciences. 118(6). 20 indexed citations

4.

Doane, Ashley S., Chi-Shuen Chu, Dafne Campigli Di Giammartino, et al.. (2021). OCT2 pre-positioning facilitates cell fate transition and chromatin architecture changes in humoral immunity. Nature Immunology. 22(10). 1327–1340. 10 indexed citations

5.

Chu, Chi-Shuen, Johannes C. Hellmuth, Rajat Singh, et al.. (2020). Unique Immune Cell Coactivators Specify Locus Control Region Function and Cell Stage. Molecular Cell. 80(5). 845–861.e10. 20 indexed citations

6.

Jishage, Miki, Keiichi Ito, Chi-Shuen Chu, et al.. (2020). Transcriptional down-regulation of metabolic genes by Gdown1 ablation induces quiescent cell re-entry into the cell cycle. Genes & Development. 34(11-12). 767–784. 4 indexed citations

7.

Lu, Xiangdong, Chi-Shuen Chu, Terry Fang, et al.. (2019). MTA2/NuRD Regulates B Cell Development and Cooperates with OCA-B in Controlling the Pre-B to Immature B Cell Transition. Cell Reports. 28(2). 472–485.e5. 26 indexed citations

8.

Hellmuth, Johannes C., Chi-Shuen Chu, Rajat Singh, et al.. (2019). An OCT2 / OCA-B / MEF2B Ternary Complex Controls the Activity and Architecture of an Essential Locus Control Region for Normal and Malignant Germinal Center B-Cells. Blood. 134(Supplement_1). 24–24.

9.

Chu, Chi-Shuen, Pang‐Hung Hsu, Yu‐Ching Teng, et al.. (2014). O-GlcNAcylation regulates EZH2 protein stability and function. Proceedings of the National Academy of Sciences. 111(4). 1355–1360. 186 indexed citations

10.

Chu, Chi-Shuen, Pang‐Hung Hsu, Elisabeth Scheer, et al.. (2011). Protein Kinase A-mediated Serine 35 Phosphorylation Dissociates Histone H1.4 from Mitotic Chromosome. Journal of Biological Chemistry. 286(41). 35843–35851. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact